FrancophonIA/ELRC3.0 huggingface dataset:
English: NAME OF THE MEDICINAL PRODUCT Trizivir 300 mg/150 mg/300 mg film-coated tablets abacavir/lamivudine/zidovudine
Slovenian: Trizivir 300 mg/150 mg/300 mg filmsko obložene tablete abakavir/lamivudin/zidovudin
English: Retinoid compounds (e.g. isotretinoin)/Zidovudine
Slovenian: retinoidne sestavine (npr. izotretinoin)/lamivudin
English: After a median follow-up of 32 weeks, the tritherapy with the three nucleosides ZDV/3TC/ABC was shown to be virologically inferior to the two other arms regardless of baseline viral load (< or > 100 000 copies/ml) with 26 % of subjects on the ZDV/3TC/ABC arm, 16 % on the ZDV/3TC/EFV arm and 13 % on the 4 drug arm categorised as having virological failure (HIV RNA >200 copies/ml).
Slovenian: Virološki neuspeh (HIV RNA > 200 kopij/ml) je bil opažen pri 26 % oseb, ki so prejemale ZDV/3TC/ABC, 16 % oseb, ki so prejemale ZDV/3TC/EFV in 13 % oseb, ki so prejemale 4 zdravila.
English: • fever (high temperature)
Slovenian: • povišana telesna temperatura (vročina), • splošno slabo počutje,
English: The clinically relevant toxicological effects of these three medicinal products are anaemia, neutropenia and leucopenia.
Slovenian: Podatkov o zdravljenju živali s kombinacijo abakavir, lamivudin in zidovudin ni. Klinično pomembni toksikološki učinki teh treh učinkovin so anemija, nevtropenija in levkopenija.
English: Lipoatrophy
Slovenian: Laktacidoza
English: Lymphopenia
Slovenian: Lipoatrofija
English: Valproic acid/Lamivudine
Slovenian: valprojska kislina/lamivudin
English: A very rare side effect that may show up in blood tests is:  a failure of the bone marrow to produce new red or white blood cells (aplastic anaemia)
Slovenian: Zelo redek neželen učinek, ki ga lahko pokažejo preiskave krvi, je:  nezmožnost kostnega mozga za tvorbo novih rdečih ali belih krvnih celic (aplastična anemija) Če se vam pojavijo neželeni učinki Če katerikoli neželeni učinek postane resen ali moteč ali če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
English: • development of 1 or more symptom from at least 2 of the following groups: - Fever - Shortness of breath, sore throat or cough - Nausea or vomiting or diarrhoea or abdominal pain - Extreme tiredness or achiness or generally ill feeling
Slovenian: - zasoplost, boleče žrelo ali kašelj - siljenje na bruhanje ali bruhanje ali driska ali bolečine v trebuhu - huda utrujenost ali bolečine ali splošno slabo počutje
English: No Trizivir dosage adjustment necessary, unless patient has
Slovenian: Prilagoditev odmerjanja zdravila Trizivir ni potrebna,
English: How to store Trizivir
Slovenian: Shranjevanje zdravila Trizivir
English: The clinical relevance of this finding has not been determined.
Slovenian: Klinični pomen tega odkritja še ni pojasnjen.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING BLISTER CARTON x 60 FILM-COATED TABLETS
Slovenian: PODATKI NA ZUNANJI OVOJNINI ŠKATLICA ZA PRETISNE OMOTE S 60 FILMSKO OBLOŽENIMI TABLETAMI
English: In case of any symptoms suggesting hypersensitivity reactions, contact your doctor IMMEDIATELY.
Slovenian: V primeru kakršnih koli znakov, ki spominjajo na preobčutljivostne reakcije se
English: Renal clearance of zidovudine is estimated to be 0.34 l/h/kg, indicating glomerular filtration and active tubular secretion by the kidneys.
Slovenian: Ledvični očistek zidovudina ocenjujejo na 0,34 l/h/kg,
English: Since Trizivir contains abacavir some patients taking Trizivir may develop a hypersensitivity reaction (serious allergic reaction) which can be life-threatening if treatment with Trizivir is continued.
Slovenian: pojavi preobčutljivostna reakcija (huda alergijska reakcija), ki lahko ogrozi življenje, če se zdravljenje z zdravilom Trizivir nadaljuje.
English: If overdose occurs the patient should be monitored for evidence of toxicity (see section 4.8), and standard supportive treatment applied as necessary.
Slovenian: (glejte poglavje 4.8), ter po potrebi pričeti s standardnim podpornim zdravljenjem.
English: • if you are seriously overweight (especially if you are a woman) Talk to your doctor if any of these apply to you before using Trizivir.
Slovenian: • če imate močno povečano telesno maso (zlasti če ste ženska).
English: The study Data Safety Monitoring Board stopped the ZDV/3TC/ABC arm at this time based on the higher proportion of patients with virologic failure.
Slovenian: V tem času je študijski odbor za spremljanje podatkov o varnosti zaradi visokega odstotka bolnikov z virološkim neuspehom prekinil zdravljenje v skupini, ki je prejemala
English: The signs and symptoms of this HSR are listed below.
Slovenian: Preobčutljivost na abakavir Znaki in simptomi povezani s HSR so navedeni spodaj.
English: The M184V or M184I variants arise in HIV-1 infected patients treated with lamivudine-containing antiretroviral therapy.
Slovenian: Odpornost in vivo (bolniki, ki še niso bili zdravljeni) Pri z virusom HIV-1 okuženih bolnikih, ki so se zdravili s protiretrovirusnim zdravljenjem, ki je vsebovalo lamivudin, sta se pojavili varianti M184V ali M184I.
English: Your doctor may need to monitor you while you are taking Trizivir.
Slovenian: Trizivir morda moral spremljati.
English: Common: fatigue, malaise, fever
Slovenian: Pogosti: utrujenost, splošen občutek slabosti, povišana telesna temperatura
English: Do not stop taking Trizivir unless your doctor advises you to do so.
Slovenian: Pred uporabo zdravila Trizivir se posvetujte z zdravnikom, če kaj od tega velja za vas.
English: Haematological adverse reactions
Slovenian: Neželeni hematološki učinki
English: • vincristine, vinblastine or doxorubicin, to treat cancer Tell your doctor if you're taking any of these.
Slovenian: • metadon, ki se uporablja kot nadomestek heroina, • vinkristin, vinblastin ali doksorubicin za zdravljenje raka.
English: infection
Slovenian: Zdravljenje
English: Abacavir, lamivudine and zidovudine are all NRTIs, and are potent selective inhibitors of HIV-1 and HIV-2.All three medicinal products are metabolised sequentially by intracellular kinases to the respective 5′-triphosphate (TP).
Slovenian: (NRTI) in so močni selektivni inhibitorji virusa HIV-1 in HIV-2.
English: 3705 LZ Zeist
Slovenian: B*5701.
English: Diagnosis of Abacavir Hypersensitivity Reaction
Slovenian: Preobčutljivostne reakcije na abakavir
English: Other effects may show up in blood tests
Slovenian: Drugi učinki, ki se lahko pokažejo na preiskavah krvi Zdravilo Trizivir lahko povzroči tudi:
English: Other common symptoms are: • nausea (feeling sick), vomiting (being sick), diarrhoea, abdominal (stomach) pain, severe tiredness
Slovenian: • slabost v želodcu (siljenje na bruhanje), bruhanje, driska, bolečine v trebuhu, huda utrujenost.
English: Monitor phenytoin concentrations.
Slovenian: Kontrolirajte koncentracijo fenitoina fenitoin/lamivudin
English: Very rarely, patients who have taken medicines containing abacavir in the past without any symptoms of hypersensitivity have developed a hypersensitivity reaction when they start taking these medicines again.
Slovenian: Zelo redko so se preobčutljivostne reakcije pojavile pri bolnikih, ki so znova začeli jemati zdravila,
English: Zidovudine
Slovenian: Zidovudin
English: You are more likely to develop such a reaction if you have a gene called HLA-B*5701 (but you can get a reaction even if you do not have this gene).
Slovenian: Verjetnost zanjo je večja, če imate gen HLA-B*5701.
English: Very common: headache Common: dizziness Rare: insomnia, paraesthesia, somnolence, loss of mental acuity, convulsions
Slovenian: Zelo pogosti: navzea Pogosti: bruhanje, abdominalna bolečina in driska
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING BOTTLE LABEL x 60 FILM-COATED TABLETS
Slovenian: PODATKI NA PRIMARNI OVOJNINI NALEPKA ZA PLASTENKO S 60 FILMSKO OBLOŽENIMI TABLETAMI
English: - nausea or vomiting or diarrhoea or abdominal pain
Slovenian: - siljenje na bruhanje ali bruhanje ali driska ali bolečine v trebuhu - huda utrujenost ali bolečine ali splošno slabo počutje
English: Haematological adverse reactions with zidovudine
Slovenian: Kontrolirajte glede znakov toksičnosti zidovudina
English: • feeling sick (nausea)
Slovenian: • slabost v želodcu (navzea).
English: Nervous system disorders Common: headache
Slovenian: Zelo pogosti: glavobol Pogosti: omotica
English: Cimetidine/Lamivudine
Slovenian: kladribin/lamivudin
English: Headache, paraesthesia
Slovenian: Pogosti: glavobol, nespečnost
English: These medicines should not be used with Trizivir: • stavudine or emtricitabine, to treat HIV infection
Slovenian: • stavudina ali emtricitabina za zdravljenje okužbe s HIV,
English: Uncommon: dyspnoea Rare: cough
Slovenian: Redki: kašelj
English: Delay in stopping treatment with Trizivir after the onset of hypersensitivity may result in a life-threatening reaction.
Slovenian: Ziagen, ko se pojavi preobčutljivost, lahko povzroči življenjsko nevarne reakcije.
English: Date of first authorisation: 29/01/2010 Date of latest renewal: 18/09/2014
Slovenian: Datum prve odobritve: 29/01/2010 Datum zadnjega podaljšanja: 18/09/2014
English: If you stop treatment, your symptoms may re-appear.
Slovenian: Če ste prenehali z zdravljenjem, se vaši simptomi lahko ponovno pojavijo.
English: • Do not give this medicine to children and adolescents below 18 years since there is no relevant indication for this age group.
Slovenian: Tega zdravila ne dajajte otrokom in mladostnikom, mlajšim od 18 let, ker v tej starostni skupini ni ustrezne indikacije.
English: • Fast or irregular heart beats (called palpitations)
Slovenian: • hiter ali nereden srčni utrip (imenovan palpitacije)
English: * p < 0.001 vs Placebo;°p = 0.002 vs Placebo
Slovenian: * p< 0,001 v primerjavi s placebom;°p = 0,002 v primerjavi s placebom
English: Very rare side effects (may affect up to 1 in 10,000 people) • Other allergic reactions with swelling of the face or throat
Slovenian: Zelo redki neželeni učinki (pojavijo se lahko pri največ 1 od 10.000 bolnikov) • druge alergijske reakcije z oteklostjo obraza ali žrela
English: Baseline value (± SD)
Slovenian: Izhodiščna vrednost (±SD)
English: It has been demonstrated in vitro that the α1A:α1B binding ratio of silodosin (162:1) is extremely high.
Slovenian: In vitro je bilo dokazano, da je α1A:α1B vezavno razmerje silodozina (162:1) izjemno visoko.
English: In the table below, adverse reactions reported in all clinical studies and in the worldwide post-marketing experience for which a reasonable causal relationship exists are listed by MedDRA system organ class and frequency: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from available data).
Slovenian: V spodnji preglednici so vsi neželeni učinki, o katerih so poročali iz vseh kliničnih študij in iz globalnih izkušenj po začetku trženja, za katere obstaja razumna vzročna povezava, navedene glede na organski sistem in pogostnost po MedDRA klasifikaciji: zelo pogosti (≥ 1/10); pogosti (≥ 1/100 do < 1/10); občasni (≥ 1/1.000 do < 1/100); redki (≥ 1/10.000 do < 1/1.000); zelo redki (< 1/10.000), neznana (ni mogoče oceniti iz razpoložljivih podatkov).
English: Not known (frequency cannot be estimated from the available data) • Floppy pupil during cataract surgery (see also above, in this section)
Slovenian: Neznana (pogostnosti ni mogoče oceniti iz razpoložljivih podatkov) • ohlapna šarenica med operacijo sive mrene (glejte tudi zgoraj v tem poglavju)
English: The requirements for submission of marketing authorisation holder shall submit periodic safety update reports for this medicinal product in accordance with the requirements set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.
Slovenian: Zahteve glede predložitve rednega posodobljenega poročila o varnosti zdravila za to zdravilo so določene v seznamu referenčnih datumov EU (seznamu EURD), opredeljenem v členu 107c(7) Direktive 2001/83/ES, in vseh kasnejših posodobitvah, objavljenih na evropskem spletnem portalu o zdravilih.
English: Contact your doctor immediately if you notice any of the following allergic reactions: swelling of the face or throat, difficulty in breathing, feeling faint, itchy skin or hives since the consequences could become serious.
Slovenian: Takoj se posvetujte z zdravnkom, če opazite katere od naslednjih alergijskih reakcij: oteklost obraza ali žrela, težave z dihanjem, omotičnost, srbeča koža ali koprivnica, saj lahko njihove posledice postanejo resne.
English: • Abnormal results of liver function tests
Slovenian: • nenormalni rezultati jetrnih testov
English: • Dizziness, including dizziness when standing up (see also above, in this section)
Slovenian: • omotica, vključno z omotico ob vstajanju v pokončni položaj (glejte tudi zgoraj v tem poglavju)
English: Orthostatic hypotension may occasionally lead to syncope (see section 4.4).
Slovenian: Ortostatska hipotenzija občasno lahko vodi v sinkopo (glejte poglavje 4.4).
English: Hard capsule.
Slovenian: Trda kapsula
English: Any unused medicinal product or waste material should be disposed of in accordance with local requirements..
Slovenian: Neuporabljeno zdravilo ali odpadni material zavrzite v skladu z lokalnimi predpisi.
English: Packs of 5, 10, 20, 30, 50, 90, 100 capsules.
Slovenian: Pakiranja po 5, 10, 20, 30, 50, 90, 100 kapsul.
English: The European Medicines Agency has waived the obligation to submit the results of studies with Silodyx in all subsets of the paediatric population in BPH (see section 4.2 for information on paediatric use).
Slovenian: Evropska agencija za zdravila je odstopila od zahteve za predložitev rezultatov študij z zdravilom Silodyx za vse podskupine pediatrične populacije z BHP (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
English: If you have moderate kidney problems, your doctor will start Silodyx with caution and possibly with a lower dose (see section 3 “Dose”).
Slovenian: Če imate zmerne težave z ledvicami, bo zdravnik začel zdravljenje z zdravilom Silodyx previdno in morda z nižjim odmerkom (glejte poglavje 3 »Odmerek«).
English: Pharmacotherapeutic group: Urologicals, alpha-adrenoreceptor antagonists, ATC code: G04CA04.
Slovenian: Farmakoterapevtska skupina: zdravila za bolezni sečil, antagonisti adrenergičnih receptorjev alfa, oznaka ATC: G04CA04.
English: Silodyx has minor or moderate influence on the ability to drive and use machines.
Slovenian: Zdravilo Silodyx ima blag ali zmeren vpliv na sposobnost vožnje in upravljanja s strojev.
English: This is because some patients treated with this kind of medicine experienced a loss of muscle tone in the iris (the coloured circular part of the eye) during such a surgery.
Slovenian: To je pomembno zaradi tega, ker so nekateri bolniki, ki so bili zdravljeni s to vrsto zdravil, med takšno operacijo izgubili mišični tonus v šarenici (obarvanem kolobarjastem delu očesa).
English: Do not drive or operate machines if you feel faint, dizzy, drowsy or have blurred vision.
Slovenian: Ne vozite avtomobila in ne upravljajte s stroji, če občutite omedlevico, omotico, zaspanost ali če imate motnje vida.
English: Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in adult men.
Slovenian: Zdravljenje znakov in simptomov benigne hiperplazije prostate (BHP) pri odraslih moških.
English: Tachycardia1 Palpitations1
Slovenian: Srčne bolezni tahikardija1 palpitacije1
English: Discontinuing treatment with an α1-blocker 1-2 weeks prior to cataract surgery has been recommended, but the benefit and duration of stopping the therapy prior to cataract surgery has not yet been established.
Slovenian: Prekinitev zdravljenja z zaviralcem α1 receptorjev 1-2 tedna pred operacijo sive mrene je priporočljiva, vendar pa korist in časovni interval prekinitve zdravljenja nista ocenjena.
English: Teл.
Slovenian: Тел.
English: • If you have ever fainted or felt dizzy when suddenly standing up, please inform your doctor before taking Silodyx.
Slovenian: • Če ste kdajkoli omedleli ali občutili omotico ob nenadnem vstajanju v pokončni položaj, povejte svojemu zdravniku pred pričetkom jemanja zdravila Silodyx.
English: It is important that you immediately inform your eye specialist if you are using or have previously used Silodyx.
Slovenian: Pomembno je, da takoj obvestite svojega očesnega zdravnika, če uporabljate ali ste v preteklosti uporabljali zdravilo Silodyx.
English: Patients should be informed about the possible occurrence of symptoms related to postural hypotension (such as dizziness) and should be cautioned about driving or operating machines until they know how silodosin will affect them.
Slovenian: Vseeno je treba bolnike opozoriti na možne simptome, povezane s posturalno hipotenzijo (kot je omotičnost) in na potrebno previdnost pri vožnji ali upravljanju s stroji, dokler ne ugotovijo, kako bo silodozin vplival nanje.
English: Silodyx is available in packs containing 5, 10, 20, 30, 50, 90, 100 capsules.
Slovenian: Zdravilo Silodyx je na voljo v pakiranjih po 5, 10, 20, 30, 50, 90, 100 kapsul.
English: • Abnormal ejaculation (less or no noticeable semen is released during sex, see section “Warnings and precautions”)
Slovenian: • nenormalna ejakulacija (izliv sperme) (pri spolnem odnosu se izlije manj ali nič sperme, glejte poglavju »Opozorila in previdnostni ukrepi«)
English: No. of patients
Slovenian: Število bolnikov
English: This causes an improvement of both storage (irritative) and voiding (obstructive) symptoms (Lower urinary tract symptoms, LUTS) associated with benign prostatic hyperplasia.
Slovenian: To povzroči izboljšanje tako iritacijskih kot tudi obstrukcijskih simptomov (neprijetnih simptomov mokrenja; LUTS-Lower urinary tract symptoms), povezanih z benigno hiperplazijo prostate.
English: • If you have severe liver problems, you should not take Silodyx, as it was not tested in this condition.
Slovenian: • Če imate hude težave z jetri, ne smete jemati zdravila Silodyx, ker zdravilo pri takih bolnikih ni bilo preizkušeno.
English: Dizziness when standing up and occasionally fainting may occur when taking Silodyx, particularly when starting treatment or if you are taking other medicines that lower blood pressure.
Slovenian: Ob jemanju zdravila Silodyx se lahko pojavita omotica ob vstajanju v pokončni položaj in občasno tudi omedlevica, še zlasti na začetku zdravljenja ali če jemljete druga zdravila za zniževanje krvnega tlaka.
English: What you need to know before you take Silodyx Do not take Silodyx if you are allergic to silodosin or any of the other ingredients of this medicine (listed in section 6).
Slovenian: Ne jemljite zdravila Silodyx če ste alergični na silodozin ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
English: Dizziness, including dizziness when standing up, and occasionally fainting, may occur.
Slovenian: Pojavita se lahko omotica, vključno z omotico ob vstajanju v pokončni položaj, in občasno omedlevica.
English: If you become dizzy or feel weak, tell your doctor straight away.
Slovenian: Če postanete omotični ali šibki, takoj obvestite svojega zdravnika.
English: This effect disappears after discontinuation of silodosin (see section 4.8).
Slovenian: Ta učinek izzveni po prekinitvi zdravljenja s silodozinom (glejte poglavje 4.8).
English: 5 hard capsules 10 hard capsules 20 hard capsules 30 hard capsules 50 hard capsules 90 hard capsules 100 hard capsules
Slovenian: 5 trdih kapsul 10 trdih kapsul 20 trdih kapsul 30 trdih kapsul 50 trdih kapsul 90 trdih kapsul 100 trdih kapsul
English: Pregnancy and breast-feeding Not applicable as silodosin is intended for male patients only.
Slovenian: Nosečnost in dojenje Navedba smiselno ni potrebna, saj je silodozin namenjen samo bolnikom moškega spola.
English: The capsule should not be broken or chewed but swallowed whole, preferably with a glass of water.
Slovenian: Kapsule se ne sme odpirati ali žvečiti, treba je pogoltniti celo, najbolje s kozarcem vode.
English: For special patient populations, one capsule of Silodyx 4 mg daily is recommended (see below).
Slovenian: Pri posebnih skupinah bolnikov je priporočena ena kapsula zdravila Silodyx 4 mg na dan (glejte spodaj).
English: • If you are undergoing eye surgery because of cloudiness of the lens (cataract surgery), it is important that you immediately inform your eye specialist that you are using or have previously used Silodyx.
Slovenian: • Če se pripravljate na očesno operacijo zaradi zamotnitve očesne leče (katarakta, operacija sive mrene), je pomembno, da takoj poveste svojemu očesnemu zdravniku, da uporabljate ali ste uporabljali zdravilo Silodyx.
English: Do not break or chew the capsule, but swallow it whole, preferably with a glass of water.
Slovenian: Kapsule ne odpirajte in ne žvečite, ampak pogoltnite celo, najbolje s kozarcem vode.
English: Silodyx belongs to a group of medicines called alpha1A-adrenoreceptor blockers.
Slovenian: Silodyx sodi v skupino zdravil, imenovanih zaviralci alfa1A-adrenergičnih receptorjev.
English: Ελλάδα ΒΙΑΝΕΞ Α.Ε.
Slovenian: Ελλάδα
English: Silodyx does not treat prostate cancer.
Slovenian: Zdravilo Silodyx ne zdravi raka prostate.
English: Other medicines and Silodyx
Slovenian: Druga zdravila in zdravilo Silodyx
English: The safety of silodosin has been evaluated in four Phase II-III double-blind controlled clinical studies (with 931 patients receiving silodosin 8 mg once daily and 733 patients receiving placebo) and in two long-term open-label extension phase studies.
Slovenian: Varnost silodozina je bila ovrednotena v štirih dvojno slepih nadzorovanih kliničnih študijah II-III Faze (z 931 bolniki, ki so prejemali 8 mg silodozina enkrat na dan in 733 bolniki, ki so prejemali placebo) in v dveh dolgoročnih odprtih podaljšanih študijah.
English: Elderly No dose adjustment is required in the elderly (see section 5.2).
Slovenian: Starejši Pri starejših bolnikih prilagajanje odmerka ni potrebno (glejte poglavje 5.2).
English: This effect disappears after discontinuation of Silodyx.
Slovenian: Ta učinek izzveni po prekinitvi zdravljenja z zdravilom Silodyx.
English: • medicines for epilepsy or rifampicin (a medicine to treat tubercolosis), since the effect of Silodyx may be reduced.
Slovenian: • zdravila za zdravljenje epilepsije ali rifampicin (zdravilo za zdravljenje tuberkuloze), ker se učinek zdravila Silodyx lahko zmanjša.
English: Silodyx may cause complications during a cataract surgery (eye surgery because of cloudiness of the lens, see section “Warnings and precautions”).
Slovenian: Zdravilo Silodyx lahko povzroči zaplete med operacijo sive mrene (operacija očesa zaradi zamotnitve leče, glejte poglavje »Opozorila in previdnostni ukrepi«).
English: In a Phase IV clinical trial performed in Europe, with a mean baseline IPSS total score of 18.9 points, 77.1% were responders to silodosin (as assessed by a change from baseline in the IPSS total score of at least 25%).
Slovenian: V klinični študiji IV. Faze, izpeljani v Evropi, s povprečnim izhodiščnim rezultatom vprašalnika IPSS 18,9 točk, se je 77,1%, bolnikov odzvalo na silodozin (kot je bilo ocenjeno s spremembo izhodiščnega rezultata vprašalnika IPSS za vsaj 25%).
English: If you have severe kidney problems, you should not take Silodyx.
Slovenian: Če imate hude težave z ledvicami, ne smete jemati zdravila Silodyx.
English: What Silodyx is and what it is used for What you need to know before you take Silodyx How to take Silodyx
Slovenian: Kaj je zdravilo Silodyx in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Silodyx Kako jemati zdravilo Silodyx Možni neželeni učinki
English: Paediatric population Silodosin has not been evaluated in patients less than 18 years of age.
Slovenian: Pediatrična populacija Uporaba silodozina pri bolnikih, mlajših od 18 let, ni bila ovrednotena.